QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: mol.108.048884v1 74/3/585    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Barak, L. S. Articles by Gainetdinov, R. R. Search for Related Content PubMed PubMed Citation Articles by Barak, L. S. Articles by Gainetdinov, R. R.

Pharmacological Characterization of Membrane-Expressed Human Trace Amine-Associated Receptor 1 (TAAR1) by a Bioluminescence Resonance Energy Transfer cAMP Biosensor

Departments of Cell Biology (L.S.B., A.S., X.Z., B.M., T.D.S., A.J.R., M.G.C., R.R.G.) and Biochemistry (J.D.V., R.J.L.) and the Howard Hughes Medical Institute (J.D.V., R.J.L.), Duke University, Durham, North Carolina

Trace amines are neurotransmitters whose role in regulating invertebrate physiology has been appreciated for many decades. Recent studies indicate that trace amines may also play a role in mammalian physiology by binding to a novel family of G protein-coupled receptors (GPCRs) that are found throughout the central nervous system. A major obstacle impeding the careful pharmacological characterization of trace amine associated receptors (TAARs) is their extremely poor membrane expression in model cell systems, and a molecular basis for this phenomenon has not been determined. In the present study, we show that the addition of an asparagine-linked glycosylation site to the N terminus of the human trace amine associated receptor 1 (TAAR1) is sufficient to enable its plasma membrane expression, and thus its pharmacological characterization with a novel cAMP EPAC (exchange protein directly activated by cAMP) protein based bioluminescence resonance energy transfer (BRET) biosensor. We applied this novel cAMP BRET biosensor to evaluate the activity of putative TAAR1 ligands. This study represents the first comprehensive investigation of the membrane-expressed human TAAR1 pharmacology. Our strategy to express TAARs and to identify their ligands using a cAMP BRET assay could provide a foundation for characterizing the functional role of trace amines in vivo and suggests a strategy to apply to groups of poorly expressing GPCRs that have remained difficult to investigate in model systems.

Received for publication May 15, 2008.

Accepted for publication June 3, 2008.

Address correspondence to: Marc G. Caron, Box 3287, Duke University, Durham, NC 27710. E-mail: m.caron{at}cellbio.duke.edu

This article has been cited by other articles:

				T. D. Sotnikova, M. G. Caron, and R. R. Gainetdinov Trace Amine-Associated Receptors as Emerging Therapeutic Targets Mol. Pharmacol., August 1, 2009; 76(2): 229 - 235. [Abstract] [Full Text] [PDF]

				J. J. Maguire, W. A. E. Parker, S. M. Foord, T. I. Bonner, R. R. Neubig, and A. P. Davenport International Union of Pharmacology. LXXII. Recommendations for Trace Amine Receptor Nomenclature Pharmacol. Rev., March 1, 2009; 61(1): 1 - 8. [Abstract] [Full Text] [PDF]